Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Paraschos Archontakis Barakakis, Thuonghien Tran, Jee Young You, Gabriel J Hernandez Romero, Vipul Gidwani, Fernando J Martinez & Spyridon Fortis. (2023) High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 469-482.
Read now
Read now
Victoria Neches García, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, Antoni Sicras-Mainar, Aram Sicras-Navarro, Cruz González, Rafael Cuervo, Soham Shukla & Marcos García-Peñuela. (2022) Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2161-2174.
Read now
Read now
Antoni Sicras-Mainar, Francisco J de Abajo & José Luis Izquierdo-Alonso. (2020) Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3291-3302.
Read now
Read now
Sergey Avdeev, Zaurbek Aisanov, Vladimir Arkhipov, Andrey Belevskiy, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2019) Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1267-1280.
Read now
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Read now
Cheng-Yi Wang, Chih-Cheng Lai, Wei-Chih Yang, Chia-Chieh Lin, Likwang Chen, Hao-Chien Wang & Chong-Jen Yu. (2016) The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2775-2783.
Read now
Read now
Shih-Lung Cheng & Ching-Hsiung Lin. (2016) Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2341-2348.
Read now
Read now
Jinming Gao & Roy A Pleasants. (2015) Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 775-789.
Read now
Read now
Articles from other publishers (9)
Yun Su Sim, Jin Hwa Lee, Eung Gu Lee, Joon Young Choi, Chang-Hoon Lee, Tai Joon An, Yeonhee Park, Young Soon Yoon, Joo Hun Park & Kwang Ha Yoo. (2022) COPD Exacerbation-Related Pathogens and Previous COPD Treatment. Journal of Clinical Medicine 12:1, pages 111.
Crossref
Crossref
Mingjin Yang, Yuejun Du, Hong Chen, Depeng Jiang & Zhibo Xu. (2019) Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials. International Immunopharmacology 77, pages 105950.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, E. I. Shmelev & M. Miravitls. (2019) Withdrawal of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Russian Pulmonology 29:3, pages 334-345.
Crossref
Crossref
Ali Abdolahinia, Mohsen Naseri, Alireza Eslaminejad, Farzaneh Ghaffari & Aliakbar Velayati. (2018) Effect of Nepeta bracteata Benth. on Chronic Obstructive Pulmonary Disease: A Triple-Blinded, Randomized Clinical Trial. Iranian Red Crescent Medical Journal 20:12.
Crossref
Crossref
Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M.E. Franssen, Klaus F. Rabe & Alberto Papi. (2018) Inhaled corticosteroids in COPD: friend or foe?. European Respiratory Journal 52:6, pages 1801219.
Crossref
Crossref
Samatha Sonnappa, Richard Martin, Elliot Israel, Dirkje Postma, Wim van Aalderen, Annie Burden, Omar S. Usmani & David B. Price. (2017) Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids. PLOS ONE 12:6, pages e0178112.
Crossref
Crossref
Jun-Jun Yeh, Yu-Chiao Wang & Chia-Hung Kao. (2016) Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism. PLOS ONE 11:9, pages e0162483.
Crossref
Crossref
Oriol Sibila, Natalia Soto-Gomez & Marcos I. Restrepo. (2015) The risk and outcomes of pneumonia in patients on inhaled corticosteroids. Pulmonary Pharmacology & Therapeutics 32, pages 130-136.
Crossref
Crossref
Courtney Crim, Mark T. Dransfield, Jean Bourbeau, Paul W. Jones, Nicola A. Hanania, Donald A. Mahler, Jørgen Vestbo, Andrew Wachtel, Fernando J. Martinez, Frank Barnhart, Sally Lettis & Peter M. A. Calverley. (2015) Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD. Annals of the American Thoracic Society 12:1, pages 27-34.
Crossref
Crossref